We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+10.77%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$19.5B
AUM Growth
+$4.2B
(+27%)
Cap. Flow
+$3.06B
Cap. Flow
% of AUM
15.66%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
1,184
New
406
Increased
253
Reduced
226
Closed
288
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.23% |
| 2 | Technology | 20.39% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 8.95% |
| 5 | Communication Services | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WWE
351
DELISTED
World Wrestling Entertainment
WWE
| $13.1M | 0.07% |
+324,144
| New | +$14.2M |
|
|
352
Fidelity National Information Services
FIS
$22.1B
| $13.1M | 0.07% |
88,860
-826,290
| -90% | -$119M |
|
353
Intellia Therapeutics
NTLA
$1.53B
| $13M | 0.07% |
653,119
-217,788
| -25% | -$4.54M |
|
354
CALL
Royal Caribbean
RCL
$87.6B
| $12.9M | 0.07% |
+200,000
| New | +$11.8M |
|
|
STMP
355
DELISTED
Stamps.com, Inc.
STMP
| $12.9M | 0.07% |
53,665
-9,588
| -15% | -$2.29M |
|
356
Cogent Communications
CCOI
$644M
| $12.9M | 0.07% |
215,065
+124,142
| +137% | +$9.06M |
|
|
OTIC
357
DELISTED
Otonomy, Inc.
OTIC
| $12.9M | 0.07% |
3,184,497
+2,210,238
| +227% | +$8.33M |
|
|
CALA
358
DELISTED
Calithera Biosciences, Inc
CALA
| $12.9M | 0.07% |
186,375
-18,697
| -9% | -$1.63M |
|
359
Assurant
AIZ
$14.9B
| $12.8M | 0.07% |
105,894
+34,160
| +48% | +$3.92M |
|
360
McCormick & Company Non-Voting
MKC
$14.1B
| $12.8M | 0.07% |
131,602
+90,802
| +223% | +$8.89M |
|
361
Stanley Black & Decker
SWK
$15.6B
| $12.8M | 0.07% |
+78,743
| New | +$12.3M |
|
|
ZGNX
362
DELISTED
Zogenix, Inc.
ZGNX
| $12.7M | 0.07% |
708,462
+542,954
| +328% | +$13.3M |
|
363
Universal Health Services
UHS
$10.4B
| $12.7M | 0.06% |
+118,232
| New | +$12.6M |
|
364
CALL
Pinterest
PINS
$13.1B
| $12.5M | 0.06% |
+300,000
| New | +$9.78M |
|
|
SURF
365
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $12.4M | 0.06% |
+1,804,020
| New | +$10.9M |
|
366
Expedia Group
EXPE
$38.4B
| $12.4M | 0.06% |
135,522
-549,495
| -80% | -$49.4M |
|
|
APTO
367
DELISTED
Aptose Biosciences, Inc.
APTO
| $12.4M | 0.06% |
+4,593
| New | +$11.5M |
|
368
AES
AES
$10.5B
| $12.3M | 0.06% |
680,946
+478,636
| +237% | +$8M |
|
369
DaVita
DVA
$12.1B
| $12.3M | 0.06% |
+143,690
| New | +$12.3M |
|
370
Charles River Laboratories
CRL
$12.6B
| $12.1M | 0.06% |
+53,472
| New | +$11.1M |
|
371
10x Genomics
TXG
$6.03B
| $12.1M | 0.06% |
97,077
+55,992
| +136% | +$5.88M |
|
372
Brinker International
EAT
$9.69B
| $12.1M | 0.06% |
283,223
+54,189
| +24% | +$1.89M |
|
|
X
373
DELISTED
US Steel
X
| $12M | 0.06% |
+1,634,933
| New | +$12.4M |
|
374
Neurogene
NGNE
$718M
| $12M | 0.06% |
49,985
+25,435
| +104% | +$6.16M |
|
375
Fulcrum Therapeutics
FULC
$288M
| $12M | 0.06% |
1,510,000
+1,249,303
| +479% | +$15M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q3 2020 Portfolio in Review
As of Q3 2020, Point72 Asset Management held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Asset Management deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Point72 Asset Management's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Point72 Asset Management added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Point72 Asset Management's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Point72 Asset Management fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Point72 Asset Management's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Point72 Asset Management opened 406 new positions and closed 288 in Q3 2020.
- Point72 Asset Management's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.